Vascular health in Kawasaki disease

Elif Seda Selamet Tierney1, Dana Gal2, Kimberly Gauvreau2

  • 1Department of Cardiology, Boston Children's Hospital, and Department of Pediatrics, Harvard Medical School, Boston, Massachusetts; Division of Pediatric Cardiology, Department of Pediatrics, Stanford University, Stanford, California.

Insights

Kawasaki disease (KD) patients show normal peripheral vascular health indices, including endothelial function and intima-media thickness, years after illness. This study provides reassurance for long-term vascular outcomes in individuals with a history of KD.

Area of Science:

  • Cardiovascular Research
  • Pediatric Cardiology
  • Vascular Biology

Background:

  • Conflicting literature exists regarding peripheral vascular health following Kawasaki disease (KD).
  • Long-term vascular sequelae in KD patients require further investigation.

Purpose of the Study:

  • To compare vascular health indices in Kawasaki disease (KD) patients with healthy controls.
  • To assess endothelial function, carotid intima-media thickness (IMT), and arterial stiffness in a cohort of KD survivors.

Main Methods:

  • A cohort of 203 KD patients (11-29 years old, KD onset >12 months prior) and 50 controls were evaluated.
  • Vascular parameters included Endothelial Pulse Amplitude Testing (Endo-PAT) index, carotid IMT (RCCA/LCCA), lipid profile, and C-reactive protein (CRP).
  • KD patients were stratified by coronary artery (CA) status: normal, mild ectasia, aneurysm, or giant aneurysm.

Main Results:

  • KD patients exhibited higher peak velocity and pulsatility index in the left common carotid artery (LCCA) compared to controls.
  • No significant differences were observed in Endothelial Pulse Amplitude Testing (Endo-PAT) index, carotid intima-media thickness (IMT), or arterial stiffness.
  • Mean LCCA IMT showed a trend towards difference across groups, with a higher mean in the giant aneurysm group (Group IV).

Conclusions:

  • Kawasaki disease (KD) patients with normal or mildly ectatic coronary arteries demonstrate normal peripheral vascular health indices.
  • Findings suggest reassurance regarding peripheral vascular health in KD survivors, contrasting some prior reports.
  • Long-term vascular assessment in KD patients is crucial, particularly for those with coronary artery abnormalities.
Abstract

Related Concept Videos

Rheumatic Heart Disease I: Introduction01:23

Rheumatic Heart Disease I: Introduction

Rheumatic heart disease or RHD is a chronic condition that results from rheumatic fever, causing permanent damage to the heart valves.Etiology and Risk FactorsIt primarily arises from rheumatic fever, an inflammatory disease that can develop after untreated or inadequately treated group A streptococcal (GAS) pharyngitis. Streptococcus spreads through direct contact with oral or respiratory secretions. While the bacteria are the causative agents, factors like malnutrition, overcrowding, poor...
Rheumatic Heart Disease II: Clinical Manifestations and Diagnostic Studies01:22

Rheumatic Heart Disease II: Clinical Manifestations and Diagnostic Studies

The key clinical manifestations of Rheumatic heart disease (RHD) include several distinct cardiac symptoms.Carditis, a hallmark of acute rheumatic fever, involves inflammation of the heart's endocardium, myocardium, and pericardium. Chronic RHD often results from recurrent episodes of carditis. Its symptoms include the following:Murmurs are caused by valvular damage, especially to the mitral and aortic valves. Mitral stenosis or regurgitation is common, with characteristic heart murmurs...
Rheumatic Heart Disease IV: Nursing Management01:20

Rheumatic Heart Disease IV: Nursing Management

AssessmentA comprehensive assessment is essential in managing a patient with rheumatic heart disease (RHD). Begin with obtaining a detailed medical history, including recent streptococcal infections, a history of rheumatic fever, or previously diagnosed rheumatic heart disease. Assess the patient for symptoms such as fever, chest pain, widespread joint pain (arthralgia), tachycardia, pericardial friction rub, muffled heart sounds, heart murmurs, peripheral edema, subcutaneous nodules, and...
Rheumatic Heart Disease III: Medical Management01:21

Rheumatic Heart Disease III: Medical Management

Rheumatic heart disease (RHD) management can be divided into two main strategies: prevention and long-term management.Primary PreventionPrimary prevention focuses on timely diagnosis and management of group A streptococcal pharyngitis to prevent acute rheumatic fever. The most widely used antibiotic for treating this condition is intramuscular benzathine penicillin G.Acute Rheumatic Fever TreatmentThe primary treatment goal for a patient diagnosed with acute rheumatic fever is to suppress the...
Endocarditis II: Clinical Features of Infective Endocarditis01:25

Endocarditis II: Clinical Features of Infective Endocarditis

Endocarditis can present various clinical features depending on the causative organism and the patient's underlying health conditions. Initially, the clinical features of infective endocarditis develop gradually, presenting with nonspecific symptoms that can be easily mistaken for other illnesses.General SymptomsEarly symptoms of infective endocarditis are fever, chills, weakness, malaise, fatigue, and weight loss. These symptoms reflect the systemic nature of the infection and the body's...
Coronary Artery Disease II: Pathophysiology01:26

Coronary Artery Disease II: Pathophysiology

Coronary Artery Disease (CAD) originates from a series of events that impair the function of coronary arteries, the blood vessels responsible for delivering oxygen-rich blood to the heart muscle. The pathophysiology of CAD is closely linked to atherosclerosis, a chronic inflammatory and lipid-driven condition affecting the vascular endothelium.1. Endothelial DamageThe process begins with damage to the vascular endothelium, which serves as a protective barrier between the blood and the vessel...